LUCKWEL PHARMACEUTICALS INC.

(LWEL)
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Otc Markets
09/10/2021 09/23/2021 10/13/2021 Date
7.0001(c) 2(c) 3.5(c) Last
0 0 350 1 000 200 Volume
-71.43% +75.00% Change
More quotes
Estimated financial data (e) (USD)
Sales 2020 - - -
Net income 2020 -0,54 M - -
Net Debt 2020 1,12 M - -
P/E ratio 2020 -1 069x
Yield 2020 -
Sales 2021 - - -
Net income 2021 -0,44 M - -
Net Debt 2021 0,01 M - -
P/E ratio 2021 -3 299x
Yield 2021 -
Capitalization 515 M 515 M -
EV / Sales 2020 -
EV / Sales 2021 -
Nbr of Employees 1
Free-Float 10,1%
More Financials
Company
Luckwel Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company is focused on the development and commercialization of therapies to combat HIV/AIDS, autoimmune disease and infectious diseases. Its pipeline includes LWEL-120 for the treatment of rheumatoid arthritis (RA); LWEL-2119 for the treatment of human immunodeficiency virus (HIV), and LWEL-2120 for the treatment of COVID-19. 
Sector
Investment Holding Companies
Calendar
-
More about the company
All news about LUCKWEL PHARMACEUTICALS INC.
2021LUCKWEL PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Financial State..
AQ
2021LUCKWEL PHARMACEUTICALS : Changes in Registrant's Certifying Accountant, Non-Reliance on P..
AQ
2021LUCKWEL PHARMACEUTICALS INC. : Changes in Registrant's Certifying Accountant, Non-Reliance..
AQ
2021LUCKWEL PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and ..
AQ
2021LUCKWEL PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and ..
AQ
2021Luckwel Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended June ..
CI
2021LUCKWEL PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and ..
AQ
2021Luckwel Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended March 31,..
CI
2021LUCKWEL PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Unregistered Sa..
AQ
2021Luckwel Pharmaceuticals Inc. announced that it expects to receive $0.075 million in fun..
CI
2021LUCKWEL PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Unregistered Sa..
AQ
2021Luckwel Pharmaceuticals Inc. announced that it expects to receive $0.12 million in fund..
CI
2021LUCKWEL PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
2021LUCKWEL PHARMACEUTICALS INC. : Unregistered Sale of Equity Securities (form 8-K)
AQ
2021LUCKWEL PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
More news
News in other languages on LUCKWEL PHARMACEUTICALS INC.

- No features available -

More news
Chart LUCKWEL PHARMACEUTICALS INC.
Duration : Period :
Luckwel Pharmaceuticals Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Kingrich J. Lee Chairman, President, CEO, CFO & Secretary
Sector and Competitors
1st jan.Capi. (M$)
LUCKWEL PHARMACEUTICALS INC.0.00%515
INVESTOR AB (PUBL)-16.20%57 907
CK HUTCHISON HOLDINGS LIMITED3.48%25 714
GROUPE BRUXELLES LAMBERT SA-17.03%12 127
HAL TRUST-11.86%11 506
AB INDUSTRIVÄRDEN (PUBL)-9.47%11 123